Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1067Lymphoid 299Plasma cell 169Myeloid 161Classical hematology 56Thoracic 24Gastrointestinal 24Dermatologic 23Sarcoma 22Breast 21Genitourinary 20CNS 18Head & Neck 14Gynecologic 11Other 6Endocrine 4Other solid neoplasm 2Other neoplasm 2NET 2

Conditions

Precancerous Conditions 162Leukemia 43Lymphoma 42Multiple Myeloma 39Leukemia, Lymphocytic, Chronic, B-Cell 39Neoplasms, Plasma Cell 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Lymphoma, Non-Hodgkin 35Lymphoma, Mantle-Cell 35Lymphoma, Large-Cell, Immunoblastic 35Lymphoma, Large B-Cell, Diffuse 35Lymphoma, Follicular 35Monoclonal Gammopathy of Undetermined Significance 34Burkitt Lymphoma 34Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 33Lymphoma, B-Cell, Marginal Zone 33Myeloproliferative Disorders 32Myelodysplastic Syndromes 32Leukemia, Myeloid, Acute 32Hodgkin Disease 32Immunoblastic Lymphadenopathy 31Lymphoma, Large-Cell, Anaplastic 30Immunoglobulin Light-chain Amyloidosis 30Waldenstrom Macroglobulinemia 29Primary Myelofibrosis 29Thrombocythemia, Essential 28Leukemia, Hairy Cell 28Leukemia, Biphenotypic, Acute 28Lymphoma, T-Cell, Cutaneous 27Leukemia, Prolymphocytic 27

Interventions

Patient Reported Outcome Measures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Hematologic Neoplasms × Other neoplasm × Clear all
NCT07216443 2026-04-15

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Orca Biosystems, Inc.

Phase 2 Recruiting
80 enrolled
MyeloidOther hematologic neoplasmOther neoplasm

Acute Disease, Bone Marrow Diseases, Disease, Graft vs Host Disease, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Precancerous Conditions, Preleukemia, Syndrome, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Disease Attributes

NCT04663100 2023-12-04

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

University of Tennessee

Phase NA Unknown
30 enrolled
LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Multiple Chronic Conditions, Leukemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡